Related Experiment Video
Updated: Dec 25, 2025
03:45
Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model
Published on: August 8, 2022
4.1K
Amyloid cardiomyopathy.
Lucie Karafiatova1, Tomas Pika2
1Department of Internal Medicine I - Cardiology, University Hospital Olomouc, Czech Republic.
Summary
Amyloidosis involves protein misfolding and amyloid deposition in organs, particularly the heart. Early diagnosis and multidisciplinary care are crucial for managing amyloid cardiomyopathy and improving patient outcomes.
Area of Science:
- Cardiology
- Nephrology
- Neurology
- Hematology
- Genetics
Background:
- Amyloidosis is a diverse disease group defined by amyloid deposition.
- Amyloid fibrils result from protein misfolding, leading to extracellular beta-pleated sheet structures.
- Organ involvement, including cardiac, liver, kidney, and nervous system, causes varied clinical symptoms.
Purpose of the Study:
- To provide an overview of amyloidosis.
- To detail the characteristics of cardiac amyloidosis.
- To present a structured approach for diagnosis, treatment, and prognosis.
Main Methods:
- Literature review of amyloidosis characteristics.
- Analysis of diagnostic criteria for cardiac amyloidosis.
- Synthesis of current treatment strategies and prognostic factors.
Main Results:
- Cardiac involvement is a significant negative prognostic factor in all amyloidosis types.
- Early diagnosis is critical, especially for AL amyloidosis, to enable effective hematological treatments.
- Despite advances, prognosis remains poor for patients with advanced cardiac amyloidosis.
Conclusions:
- Amyloid cardiomyopathy requires early diagnosis and multidisciplinary management.
- Timely intervention is essential for patients to be eligible for potentially curative therapies.
- Continued research is needed to improve outcomes for advanced cardiac amyloidosis.
Related Concept Videos
01:29Cardiomyopathy III: Hypertrophic Cardiomyopathy
289
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
289
01:29Cardiomyopathy V: Interprofessional Care
237
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
237
01:29Cardiomyopathy IV: Restrictive Cardiomyopathy
370
Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
370
01:30Cardiomyopathy II: Dilated Cardiomyopathy
350
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
350
01:25Cardiomyopathy I: Introduction and Classification
415
Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
415
01:21Myocarditis I: Introduction
283
Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
283